14158 Results (Page 437 of 567)
All Market Research Reports
Saudi Arabia Artificial Intelligence (AI) in Healthcare Market Analysis
Saudi Arabia's Artificial Intelligence (AI) In Healthcare Market is projected to grow from $0.12 Bn in 2022 to $2.52 Bn by 2030, registering a CAGR of 46.72% during the forecast period of 2022 - 2030. The market will be driven by the growing demand for more cost-effective healthcare solutions and the government's support for the use of artificial intelligence in healthcare. The market is segmented by healthcare components & by healthcare applications. Some of the major players include IBM Watson Health, Google DeepMind Health & Cura.
Turkey Liver Diseases Therapeutics Market Analysis
By 2030, it is anticipated that the Turkey Liver Disease Therapeutics market will reach a value of $299 Mn from $185 Mn in 2022, growing at a CAGR of 6.2 % during 2022-2030. Liver Disease Therapeutics in Turkey is dominated by a few domestic pharmaceutical companies such as Abdi İbrahim, Mustafa Nevzat, and Deva Holding. The Liver Disease Therapeutics market in Turkey is segmented into different types of disease and different therapy types. Some of the major factors affecting the Turkey Liver Disease Therapeutics market are the growing prevalence of liver diseases and unhealthy and dynamic lifestyles.
Saudi Arabia Liver Diseases Therapeutics Market Analysis
By 2030, it is anticipated that the Saudi Arabia Liver Disease Therapeutics market will reach a value of $685 Mn from $393 Mn in 2022, growing at a CAGR of 7.2% during 2022-2030. Liver Disease Therapeutics in Saudi Arabia is dominated by a few domestic pharmaceutical companies such as Tabuk Pharmaceuticals, Jamjoom Pharma, and SPIMACO. The Liver Disease Therapeutics market in Saudi Arabia is segmented into different types of disease and different therapy types. Some of the major factors affecting the Saudi Arabia Liver Disease Therapeutics market are the growing prevalence of liver diseases and unhealthy and dynamic lifestyles.
Mexico Liver Diseases Therapeutics Market Analysis
By 2030, it is anticipated that the Mexico Liver Disease Therapeutics market will reach a value of $550 Mn from $346 Mn in 2022, growing at a CAGR of 6 % during 2022-2030. Liver Disease Therapeutics in Mexico is dominated by a few domestic pharmaceutical companies such as Liomont, Laboratorios Senosiain, and Silanes Laboratorios. The Liver Disease Therapeutics market in Mexico is segmented into different types of disease and different therapy types. Some of the major factors affecting the Mexico Liver Disease Therapeutics market are the growing prevalence of liver diseases and unhealthy and dynamic lifestyles.
Indonesia Liver Diseases Therapeutics Market Analysis
By 2030, it is anticipated that the Indonesia Liver Disease Therapeutics market will reach a value of $216 Mn from $139 Mn in 2022, growing at a CAGR of 5.7% during 2022-2030. Liver Disease Therapeutics in Indonesia are dominated by a few domestic pharmaceutical companies such as Kalbe Farma, Dexa Medica, and Combiphar. The Liver Disease Therapeutics market in Indonesia is segmented into different types of disease and different therapy types. Some of the major factors affecting the Indonesia Liver Disease Therapeutics market are the growing prevalence of liver diseases and unhealthy and dynamic lifestyles.
Germany Cardiovascular Diseases Therapeutics Market Analysis
Germany's cardiovascular disease therapeutics market is expected to witness growth from $5.95 Bn in 2022 to $9.08 Bn in 2030 with a CAGR of 5.42% for the year 2022-2030. Technological advancements and supportive government policies in terms of cardiovascular diseases in Germany are responsible for the growth of the market. The Germany cardiovascular disease therapeutics market is segmented by disease indication, drug type, route of administration, drug classification, mode of purchase, and by the end user. Waypharm, Cordes Pharma, and Pfizer are the major players in the Germany cardiovascular disease therapeutics market.
France Cardiovascular Diseases Therapeutics Market Analysis
France's cardiovascular disease therapeutics market is projected to grow from $4.47 Bn in 2022 to $7.24 Bn in 2030 with a CAGR of 6.22% for the year 2022-2030. The rising prevalence of cardiovascular diseases in France and consequently increased healthcare spending in France are the major market drivers for the growth of the market. The France cardiovascular disease therapeutics market is segmented by disease indication, drug type, route of administration, drug classification, mode of purchase, and by the end user. Medac, Laboratoires Boiron, and AstraZeneca are the major players in the France cardiovascular disease therapeutics market.
China Cardiovascular Diseases Therapeutics Market Analysis
China's cardiovascular disease therapeutics market is expected to witness growth from $13.07 Bn in 2022 to $25.52 Bn in 2030 with a CAGR of 8.72% for the year 2022-30. The shifting lifestyle modifications in China have led to an increase in the prevalence of cardiovascular diseases, therefore, driving the growth of the market. The China cardiovascular disease therapeutics market is segmented by disease indication, drug type, route of administration, drug classification, mode of purchase, and by the end user. Lanrui Boyan Medical, Beijing Handian Pharmacy, and AstraZeneca are the major players in the China cardiovascular disease therapeutics market.
Brazil Cardiovascular Diseases Therapeutics Market Analysis
Brazil's cardiovascular disease therapeutics market is expected to witness growth from $4.06 Bn in 2022 to $7.64 Bn in 2030 with a CAGR of 8.22% for the forecasted year 2022-2030 due to the rising geriatric population and their subsequent demand for new and innovative therapeutic options in Brazil are responsible for the growth of the market. The Brazil cardiovascular disease therapeutics market is segmented by disease indication, drug type, route of administration, drug classification, mode of purchase, and by end user. Eurofarma, Cálamo Distribuidora, and Pfizer are the major players in the Brazil cardiovascular disease therapeutics market.
Tanzania Healthcare Insurance Market Analysis
The Tanzania healthcare insurance market is projected to grow from $810.48 Bn in 2022 to $1556.61 Bn by 2030, registering a CAGR of 8.5% during the forecast period of 2022 - 2030. The main factors driving the growth would be increasing population, technological advancements and government support. The market is segmented by component, the provider, coverage, by health insurance plans and end-user. Some of the major players include Bumaco, MyHI, Jubilee, Britam and AAR Insurance.
Tanzania Connected Healthcare Market Analysis
The Tanzania-connected healthcare market is projected to grow from $26.54 Mn in 2022 to $207.37 Mn by 2030, registering a CAGR of 29.3% during the forecast period of 2022 - 2030. The main factors driving the growth would be increased adoption of digital technology, private sector investment and government support. The market is segmented by type, function and by application. Some of the major players include LyfPlus, GPITG, Philips Healthcare, IBM and Siemens Healthineers.
South Korea Healthcare Insurance Market Analysis
The South Korean healthcare insurance market is projected to grow from $29.61 Bn in 2022 to $57.28 Bn by 2030, registering a CAGR of 8.6% during the forecast period of 2022 - 2030. The main factors driving the growth would be rising healthcare costs, increasing disposable income, government support and technological advancements. The market is segmented by the component, provider, coverage, by health insurance plans and end-user. Some of the major players include Samsung Life Insurance, Hanwha Life Insurance, Kyobo Life Insurance, KB Insurance and Cigna.
Tanzania Anti Aging Therapeutics Market Analysis
Tanzania anti-aging therapeutics market is projected to witness growth from $0 Mn in 2022 to $1 Mn in 2030 with a CAGR of 17.43% for the year 2022-2030. The rise in the aging population in Tanzania and the supportive regulatory initiatives taken by the Tanzanian government are the major market drivers for the growth of the market. The Tanzania anti-aging therapeutics market is segmented by product, treatment, target group, type of aging, type of molecules, mechanism of action, ingredient, and by distribution channel. Nashukuru Pharma, Arwa Pharmacy, and Intervene Immune are the key players in the market.
Turkey Anti Aging Therapeutics Market Analysis
Turkey anti-aging therapeutics market is projected to grow from $5 Mn in 2022 to $17 Mn in 2030 with a CAGR of 17.03% for the year 2022-2030. The emerging development and increased efforts in research for stem cell therapy in Turkey as well as rising disposable incomes in Turkey are responsible for the expansion of the market. The Turkey anti-aging therapeutics market is segmented by product, treatment, target group, type of aging, type of molecules, mechanism of action, ingredient, and by distribution channel. Some of the leading players in the market are Gene2info, Turgut Pharmaceuticals, and Biosplice.
India Anti Aging Therapeutics Market Analysis
India anti-aging therapeutics market is expected to witness growth from $11 Mn in 2022 to $46 Mn in 2030 with a CAGR of 19.53% for the year 2022-2030. The growth from the baby boomer population to the middle age population in India and their subsequent demand for ant-aging products for a more youthful appearance are the major market drivers. The India anti-aging therapeutics market is segmented by product, treatment, target group, type of aging, type of molecules, mechanism of action, ingredient, and by distribution channel. Glenmark, Navitor Pharmaceuticals, and NeuroTrack are some of the key players in the market.
Kenya Anti Aging Therapeutics Market Analysis
Kenya anti-aging therapeutics market is projected to witness growth from $0 Mn in 2022 to $2 Mn in 2030 with a CAGR of 17.63% for the year 2022-2030. The rising economy of Kenya as well as the growing awareness about the various anti-aging therapeutic options in Kenya are responsible for the expansion of the market. The Kenya anti-aging therapeutics market is segmented by product, treatment, target group, type of aging, type of molecules, mechanism of action, ingredient, and by distribution channel. Some of the key competitors in the market are Comet Healthcare, Cosmos, and Cambrian Biopharma.
UAE Anti Aging Therapeutics Market Analysis
UAE anti-aging therapeutics market is projected to grow from $3 Mn in 2022 to $11 Mn in 2030 with a CAGR of 17.53% for the year 2022-2030. The market is projected to expand as a result of the growing demand for anti-aging treatments and rising disposable incomes in the UAE. The UAE anti-aging therapeutics market is segmented by product, treatment, target group, type of aging, type of molecules, mechanism of action, ingredient, and by distribution channel. Insilico Medicine, Kuwait Saudi Pharmaceuticals, and Alkahest are the top players in the market.
Egypt Anti Aging Therapeutics Market Analysis
Egypt anti-aging therapeutics market is expected to witness growth from $2 Mn in 2022 to $6 Mn in 2030 with a CAGR of 18.03% for the year 2022-2030. Egypt’s rising elderly population and their subsequent demand for innovative anti-aging treatments are responsible for the growth of the market during the forecast period. The Egypt anti-aging therapeutics market is segmented by product, treatment, target group, type of aging, type of molecules, mechanism of action, ingredient, and by distribution channel. Some of the leading players in the market are CEB, Botogenix, and Intervene Immune.
Poland Healthcare Insurance Market Analysis
The Poland healthcare insurance market is projected to grow from $11.75 Bn in 2022 to $21.83 Bn by 2030, registering a CAGR of 8.05% during the forecast period of 2022 - 2030. The main factors driving the growth would be the digital health marketplace, rising healthcare costs, government policies and Technological advancements. The market is segmented by component, provider, coverage, by health insurance plans and end-user. Some of the major players include Luxmed, PZU Zdrowie, Inter Polska, Medicover and Allianz.
Italy Anti Aging Therapeutics Market Analysis
Italy anti-aging therapeutics market is expected to witness growth from $14 Mn in 2022 to $48 Mn in 2030 with a CAGR of 16.03% for the year 2022-2030. The rising awareness about age-related disorders among the Italian population and growing investments in anti-aging treatments in Italy by major biotechnology companies are driving the growth of the market. The Italy anti-aging therapeutics market is segmented by product, treatment, target group, type of aging, type of molecules, mechanism of action, ingredient, and by distribution channel. Recipharm, Italfarmaco, and Cambrian Biopharma are among the leading players in the market.
France Anti Aging Therapeutics Market Analysis
France anti-aging therapeutics market is expected to witness growth from $17 Mn in 2022 to $53 Mn in 2030 with a CAGR of 15.53% for the year 2022-2030. The presence of robust research and development industry in France makes it a popular destination for the testing of anti-aging therapeutics thereby resulting in the growth of the market. The France anti-aging therapeutics market is segmented by product, treatment, target group, type of aging, type of molecules, mechanism of action, ingredient, and by distribution channel. Some of the key players in the market include Cottos, DBV Technologies, and Allergan.
Spain Anti Aging Therapeutics Market Analysis
Spain anti-aging therapeutics market is projected to grow from $12 Mn in 2022 to $37 Mn in 2030 with a CAGR of 15.53% for the year 2022-2030. The rise in the aging population in Spain and the increase in affordability of the newer treatment option owing to the growing economy in Spain are the major market drivers. The Spain anti-aging therapeutics market is segmented by product, treatment, target group, type of aging, type of molecules, mechanism of action, ingredient, and by distribution channel. Some of the key players in the market are IDP Pharma, Oryzon Genomics, and Allergan.
Netherlands Connected Healthcare Market Analysis
The Netherlands-connected healthcare market is projected to grow from $172.54 Mn in 2022 to $1314.93 Mn by 2030, registering a CAGR of 28.9% during the forecast period of 2022 - 2030. The main factors driving the growth would be strong government support, digital infrastructure, the ageing population and collaborations between stakeholders. The market is segmented by type, function and by application. Some of the major players include Philips Healthcare, Easee, Roche, Medtronic and Siemens Healthineers.
Mexico Healthcare Insurance Market Analysis
The Mexico healthcare insurance market is projected to grow from $30.39 Bn in 2022 to $55.63 Bn by 2030, registering a CAGR of 7.85% during the forecast period of 2022 - 2030. The main factors driving the growth would be the growing demand for healthcare services, regulatory changes, increasing affordability and technological advancements. The market is segmented by component, provider, coverage, by health insurance plans and end-user. Some of the major players include Grupo Nacional Provincial, Grupo Financiero Banorte, AXA, Metlife and Allianz.
UK Anti Aging Therapeutics Market Analysis
UK anti-aging therapeutics market is projected to grow from $16 Mn in 2022 to $46 Mn in 2030 with a CAGR of 14.53% for the year 2022-2030. The rising geriatric population, increasing demand for anti-aging therapeutics, and rising healthcare expenditure are the major market drivers for the growth of the market. The UK anti-aging therapeutics market is segmented by product, treatment, target group, type of aging, type of molecules, mechanism of action, ingredient, and by distribution channel. Some of the key players in the market include Veristat, Genflow Biosciences, and Regenerative Medicine.
